Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - Trotabresib

Trotabresib

CAS No. 1706738-98-8

Trotabresib( —— )

Catalog No. M34836 CAS No. 1706738-98-8

Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	215	In Stock
5MG	188	In Stock
10MG	312	In Stock
25MG	528	In Stock
50MG	739	In Stock
100MG	995	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Trotabresib
Note

Research use only, not for human use.
Brief Description

Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.
Description

CC-90010 (compound 1) is a reversible and orally active BET inhibitor. CC-90010 is applied in the study for advanced solid tumors.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Chromatin/Epigenetic
Target

Epigenetic Reader Domain
Recptor

Epigenetic Reader Domain
Research Area

——
Indication

——

Chemical Information

CAS Number

1706738-98-8
Formula Weight

383.46
Molecular Formula

C21H21NO4S
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (130.39 mM; Ultrasonic )
SMILES

Cn1cc(-c2cc(ccc2OCC2CC2)S(C)(=O)=O)c2ccccc2c1=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. CELGENE QUANTICEL RESEARCH, INC. PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR. Patent. WO2020023438.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

GSK046

GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).
Alobresib

Alobresib is an inhibitor of BET bromodomain,is an antineoplastic drug candidate.
BRD4-BD1-IN-2

BRD4-BD1-IN-2 is a selective and potent BRD4-BD1 inhibitor with an IC50 value of 2.51 μM, exhibiting 20-fold greater inhibitory activity against BRD4-BD1 compared to BRD4-BD2.

Sign In Join Free